Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Harmony Biosciences Holdings, Inc. HRMY

Set alert

Price alert · HRMY

All alert types
37.91 USD -0.85 -2.19%

At close

38.00 +0.09 +0.24%

Pre-market · Nov 3, 4:52 AM ET

Bid
37.92 × 1
Ask
37.94 × 1
37.69 Day range 39.03
25.90 52-week range 43.49
YTD
+1.31%
1 year
+32.69%
Open
38.77
Prev close
38.76
Mkt cap
2.21B
Vol
993.98K
Avg vol
957.62K
EPS
3.10
P/E
12.23
Div yield
0.00%
More statistics
Low
37.69
High
39.03
Forward P/E
5.41
Beta
0.98
Short ratio
5.33
Inst. own
100.11%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
39.76
200-d avg
34.69
1y target
48.08

5D chart

Chart tools
Interval
1m5m15m30m

Signals (134)
NameTimeAgo
SMA: BearishNov 2, 1:05 PM16 hours ago
MACD: Sell SignalNov 2, 12:55 PM16 hours ago
SMA: BearishNov 2, 12:45 PM16 hours ago
SMA: BullishNov 2, 11:25 AM17 hours ago
SMA: BullishNov 2, 11:05 AM18 hours ago
SMA: BearishNov 2, 11:00 AM18 hours ago
MACD: Buy SignalNov 2, 10:45 AM18 hours ago
SMA: BullishNov 2, 10:40 AM18 hours ago
RSI: OversoldNov 2, 10:30 AM18 hours ago
RSI: OversoldNov 2, 10:15 AM18 hours ago
RSI: OversoldNov 2, 9:45 AM19 hours ago
SMA: BearishOct 30, 3:50 PM3 days ago
SMA: BullishOct 30, 3:45 PM3 days ago
SMA: BearishOct 30, 3:15 PM3 days ago
SMA: BearishOct 30, 3:15 PM3 days ago
MACD: Sell SignalOct 30, 3:15 PM3 days ago
MACD: Buy SignalOct 30, 3:10 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
SMA: BearishOct 30, 2:30 PM3 days ago

Newest 20 of 134.

Analyst view

Consensus: buy

Buy
Price target (mean) 48.08 +26.8% upside
Target (low)
30.00
Target (mean)
48.08
Target (high)
70.00
Ratings (0m) 12 8 buy · 3 hold · 1 sell
  • Strong buy2
  • Buy6
  • Hold3
  • Sell0
  • Strong sell1

Recommendation trend

  • This month 12
  • 1 month ago 11
  • 2 months ago 11

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

HRMY analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter1.471.41 – 1.531.08+35.9%272.05M+13.6%2
Next quarter1.531.45 – 1.600.57+168.0%280.05M+14.9%2
Current year5.225.13 – 5.313.60+45.0%1.03B+18.2%2
Next year7.006.98 – 7.035.22+34.1%1.17B+13.7%2

Upgrades and downgrades

The latest rating changes

HRMY analyst upgrades and downgrades
DateFirmActionFromTo
Oct 19, 2026NeedhamReiteratedBuyBuy
Oct 13, 2026HC Wainwright & Co.ReiteratedBuyBuy
Oct 12, 2026NeedhamReiteratedBuyBuy
Aug 26, 2026Wolfe ResearchInitiated—Outperform
Aug 5, 2026Truist SecuritiesMaintainedHoldHold
Aug 4, 2026NeedhamMaintainedBuyBuy
Jul 31, 2026MizuhoMaintainedOutperformOutperform
Jul 16, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jun 30, 2026Deutsche BankMaintainedHoldHold
May 8, 2026Truist SecuritiesMaintainedHoldHold
Feb 25, 2026UBSMaintainedNeutralNeutral
Feb 25, 2026HC Wainwright & Co.ReiteratedBuyBuy
Feb 25, 2026B of A SecuritiesMaintainedUnderperformUnderperform
Feb 25, 2026NeedhamMaintainedBuyBuy
Feb 11, 2026UBSDowngradeBuyNeutral
Jan 8, 2026Truist SecuritiesMaintainedBuyBuy
Dec 1, 2025MizuhoMaintainedOutperformOutperform
Nov 24, 2025HC Wainwright & Co.ReiteratedBuyBuy
Nov 24, 2025NeedhamReiteratedBuyBuy
Nov 6, 2025MizuhoMaintainedOutperformOutperform
Oct 15, 2025UBSMaintainedBuyBuy
Sep 25, 2025MizuhoMaintainedOutperformOutperform
Sep 25, 2025Deutsche BankMaintainedBuyBuy
Sep 25, 2025HC Wainwright & Co.MaintainedBuyBuy
Sep 24, 2025NeedhamMaintainedBuyBuy
Jul 21, 2025Truist SecuritiesInitiated—Buy
Jul 10, 2025Deutsche BankMaintainedBuyBuy
May 15, 2025MizuhoMaintainedOutperformOutperform
May 7, 2025NeedhamReiteratedBuyBuy
May 6, 2025NeedhamReiteratedBuyBuy